A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Aug 21, 2025 - P1 | N=94 | Terminated | Sponsor: Eli Lilly and Company | Phase classification: P1b ➔ P1 | Completed ➔ Terminated; The study was terminated due to business considerations
Phase classification • Trial termination • Biliary Cancer • Breast Cancer • Cholangiocarcinoma • Colon Cancer • Colorectal Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • Triple Negative Breast Cancer
|